Epidermal Cell Articles & Analysis
11 news found
The picosecond laser can release high heat, thereby destroying the melanin in the epidermal cells and reducing the spots. When performing picosecond lasers, the temperature setting may be too high, which will lead to obvious local burning and tingling sensations, which are relatively common side effects. ...
These two programs are currently being evaluated in Phase 2 studies, targeting a variety of late-stage, difficult-to-treat cancer types, including breast cancer for praluzatamab ravtansine, and squamous non-small cell lung cancer, and head and neck squamous cell carcinoma for CX-2029. CytomX’s clinical pipeline also includes cancer immunotherapeutic ...
CX-904 is a conditionally activated T-cell-engaging bispecific (TCB) designed to target the epidermal growth factor receptor (EGFR) on cancer cells and the CD3 receptor on T cells within the tumor microenvironment. ...
These two programs are currently being evaluated in Phase 2 studies, targeting a variety of late-stage, difficult-to-treat cancer types, including breast cancer for praluzatamab ravtansine, and squamous non-small cell lung cancer, and head and neck squamous cell carcinoma for CX-2029. CytomX’s clinical pipeline also includes cancer immunotherapeutic ...
These two programs are currently being evaluated in Phase 2 studies, targeting a variety of late-stage, difficult-to-treat cancer types, including breast cancer for praluzatamab ravtansine, and squamous non-small cell lung cancer, and head and neck squamous cell carcinoma for CX-2029. CytomX’s clinical pipeline also includes cancer immunotherapeutic ...
These two programs are currently being evaluated in Phase 2 studies, targeting a variety of late-stage, difficult-to-treat cancer types, including breast cancer for praluzatamab ravtansine, and squamous non-small cell lung cancer, and head and neck squamous cell carcinoma for CX-2029. CytomX’s clinical pipeline also includes cancer immunotherapeutic ...
The inhibition of release of inflammatory substances from skin cells irradiated with UVB-radiation were used in testing to monitor the comparison of the two substances. Although both compounds were effective in preventing the release of TNF-alpha (TNFα), only LEA™ was found to be effective in preventing the release of IL-1-beta (IL-1β) from human ...
The inhibition of release of inflammatory substances from skin cells irradiated with UVB-radiation were used in testing to monitor the comparison of the two substances. Although both compounds were effective in preventing the release of TNF-alpha (TNFα), only LEA™ was found to be effective in preventing the release of IL-1-beta (IL-1β) from human ...
Modena, 23 April 2021 – The European Research Council (ERC) yesterday announced the winners of the 2020 Advanced Grants. The grants, worth a total of €507 million, will support 209 researchers across Europe. Eight projects were won by researchers working in Italy, including the project presented by Michele De Luca, Director of the “Stefano Ferrari” Centre for Regenerative ...
The inhibition of release of inflammatory substances from skin cells irradiated with UVB-radiation were used to monitor the comparison of the two substances. Although both compounds were effective in preventing the release of TNF-alpha (TNFα), only Atopidine™ was found to be effective in preventing the release of IL-1-beta (IL-1β) from human ...
The inhibition of release of inflammatory substances from skin cells irradiated with UVB-radiation were used to monitor the comparison of the two substances. Although both compounds were effective in preventing the release of TNF-alpha (TNFα), only Atopidine™ was found to be effective in preventing the release of IL-1-beta (IL-1β) from human ...